Coma iperammoniemico in un paziente con deficit di OTC

Translated title of the contribution: Hyperammonemic coma in a patient with late-onset OTC deficiency

Valentina D’Onofrio, F. Poma, A. Enea, F. Santarelli, C. Lovera, M. Spada

Research output: Contribution to journalArticle

Abstract

Urea Cycle Disorders (UCD) are among the most common genetic diseases of the metabolism and ornithine transcarbamylase deficiency (OTC), an X-linked defect is the most frequent among them. It is responsible for hyperammonemia that can lead to chronic neurological illness and potentially to death in case of delayed diagnosis and treatment. With regards to the OTC deficiency there is great clinical heterogeneity with early-onset phenotypes with mostly poor prognosis and late-onset phenotypes with a better one. In the article it is reported the case of a 8 years old patient with diagnosis of OTC deficit with late-onset phenotype. The kid was brought to our hospital because of continuous vomiting and gastro- intestinal disorders, associated with irritability and lethargy later resulted into coma. Measurement of plasma ammonia concentration, followed by measurement of plasma amino acid and urine orotic acid levels allowed to diagnose the OTC deficit, lately confirmed by molecular genetic studies. The patient has been promptly treated with Sodium Phenylbutyrate, Arginine and discontinuing the protein intake. Gradually the ammonemia value decreased, and general and neurological conditions improved with resolution of the coma. To conclude, for patients presenting unexplained neurological symptoms, confusion and decreased level of consciousness, up to coma, urea cycle disorders and in particularly OTC deficiency should be considered in the differential diagnosis and an urgent ammonia level determined. In case of hyperammonemia, the treatment should be started immediately, even without a precise ethiologic diagnosis.

Original languageItalian
Pages (from-to)128-131
Number of pages4
JournalPediatria Medica e Chirurgica
Volume36
Issue number3
Publication statusPublished - 2014

Fingerprint

Ornithine Carbamoyltransferase Deficiency Disease
Coma
Inborn Urea Cycle Disorder
Hyperammonemia
Phenotype
Ammonia
Orotic Acid
Confusion
Lethargy
Inborn Genetic Diseases
Delayed Diagnosis
Consciousness
Vomiting
Arginine
Molecular Biology
Differential Diagnosis
Chronic Disease
Urine
Amino Acids
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

D’Onofrio, V., Poma, F., Enea, A., Santarelli, F., Lovera, C., & Spada, M. (2014). Coma iperammoniemico in un paziente con deficit di OTC. Pediatria Medica e Chirurgica, 36(3), 128-131.

Coma iperammoniemico in un paziente con deficit di OTC. / D’Onofrio, Valentina; Poma, F.; Enea, A.; Santarelli, F.; Lovera, C.; Spada, M.

In: Pediatria Medica e Chirurgica, Vol. 36, No. 3, 2014, p. 128-131.

Research output: Contribution to journalArticle

D’Onofrio, V, Poma, F, Enea, A, Santarelli, F, Lovera, C & Spada, M 2014, 'Coma iperammoniemico in un paziente con deficit di OTC', Pediatria Medica e Chirurgica, vol. 36, no. 3, pp. 128-131.
D’Onofrio V, Poma F, Enea A, Santarelli F, Lovera C, Spada M. Coma iperammoniemico in un paziente con deficit di OTC. Pediatria Medica e Chirurgica. 2014;36(3):128-131.
D’Onofrio, Valentina ; Poma, F. ; Enea, A. ; Santarelli, F. ; Lovera, C. ; Spada, M. / Coma iperammoniemico in un paziente con deficit di OTC. In: Pediatria Medica e Chirurgica. 2014 ; Vol. 36, No. 3. pp. 128-131.
@article{cd376ab13e7445529a34dd2453333ed2,
title = "Coma iperammoniemico in un paziente con deficit di OTC",
abstract = "Urea Cycle Disorders (UCD) are among the most common genetic diseases of the metabolism and ornithine transcarbamylase deficiency (OTC), an X-linked defect is the most frequent among them. It is responsible for hyperammonemia that can lead to chronic neurological illness and potentially to death in case of delayed diagnosis and treatment. With regards to the OTC deficiency there is great clinical heterogeneity with early-onset phenotypes with mostly poor prognosis and late-onset phenotypes with a better one. In the article it is reported the case of a 8 years old patient with diagnosis of OTC deficit with late-onset phenotype. The kid was brought to our hospital because of continuous vomiting and gastro- intestinal disorders, associated with irritability and lethargy later resulted into coma. Measurement of plasma ammonia concentration, followed by measurement of plasma amino acid and urine orotic acid levels allowed to diagnose the OTC deficit, lately confirmed by molecular genetic studies. The patient has been promptly treated with Sodium Phenylbutyrate, Arginine and discontinuing the protein intake. Gradually the ammonemia value decreased, and general and neurological conditions improved with resolution of the coma. To conclude, for patients presenting unexplained neurological symptoms, confusion and decreased level of consciousness, up to coma, urea cycle disorders and in particularly OTC deficiency should be considered in the differential diagnosis and an urgent ammonia level determined. In case of hyperammonemia, the treatment should be started immediately, even without a precise ethiologic diagnosis.",
keywords = "Hyperammonemic coma, OTC, Urea cycle disorder",
author = "Valentina D’Onofrio and F. Poma and A. Enea and F. Santarelli and C. Lovera and M. Spada",
year = "2014",
language = "Italian",
volume = "36",
pages = "128--131",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "3",

}

TY - JOUR

T1 - Coma iperammoniemico in un paziente con deficit di OTC

AU - D’Onofrio, Valentina

AU - Poma, F.

AU - Enea, A.

AU - Santarelli, F.

AU - Lovera, C.

AU - Spada, M.

PY - 2014

Y1 - 2014

N2 - Urea Cycle Disorders (UCD) are among the most common genetic diseases of the metabolism and ornithine transcarbamylase deficiency (OTC), an X-linked defect is the most frequent among them. It is responsible for hyperammonemia that can lead to chronic neurological illness and potentially to death in case of delayed diagnosis and treatment. With regards to the OTC deficiency there is great clinical heterogeneity with early-onset phenotypes with mostly poor prognosis and late-onset phenotypes with a better one. In the article it is reported the case of a 8 years old patient with diagnosis of OTC deficit with late-onset phenotype. The kid was brought to our hospital because of continuous vomiting and gastro- intestinal disorders, associated with irritability and lethargy later resulted into coma. Measurement of plasma ammonia concentration, followed by measurement of plasma amino acid and urine orotic acid levels allowed to diagnose the OTC deficit, lately confirmed by molecular genetic studies. The patient has been promptly treated with Sodium Phenylbutyrate, Arginine and discontinuing the protein intake. Gradually the ammonemia value decreased, and general and neurological conditions improved with resolution of the coma. To conclude, for patients presenting unexplained neurological symptoms, confusion and decreased level of consciousness, up to coma, urea cycle disorders and in particularly OTC deficiency should be considered in the differential diagnosis and an urgent ammonia level determined. In case of hyperammonemia, the treatment should be started immediately, even without a precise ethiologic diagnosis.

AB - Urea Cycle Disorders (UCD) are among the most common genetic diseases of the metabolism and ornithine transcarbamylase deficiency (OTC), an X-linked defect is the most frequent among them. It is responsible for hyperammonemia that can lead to chronic neurological illness and potentially to death in case of delayed diagnosis and treatment. With regards to the OTC deficiency there is great clinical heterogeneity with early-onset phenotypes with mostly poor prognosis and late-onset phenotypes with a better one. In the article it is reported the case of a 8 years old patient with diagnosis of OTC deficit with late-onset phenotype. The kid was brought to our hospital because of continuous vomiting and gastro- intestinal disorders, associated with irritability and lethargy later resulted into coma. Measurement of plasma ammonia concentration, followed by measurement of plasma amino acid and urine orotic acid levels allowed to diagnose the OTC deficit, lately confirmed by molecular genetic studies. The patient has been promptly treated with Sodium Phenylbutyrate, Arginine and discontinuing the protein intake. Gradually the ammonemia value decreased, and general and neurological conditions improved with resolution of the coma. To conclude, for patients presenting unexplained neurological symptoms, confusion and decreased level of consciousness, up to coma, urea cycle disorders and in particularly OTC deficiency should be considered in the differential diagnosis and an urgent ammonia level determined. In case of hyperammonemia, the treatment should be started immediately, even without a precise ethiologic diagnosis.

KW - Hyperammonemic coma

KW - OTC

KW - Urea cycle disorder

UR - http://www.scopus.com/inward/record.url?scp=84994891191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994891191&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84994891191

VL - 36

SP - 128

EP - 131

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 3

ER -